Skip to main content
OpenTrials

Clinical trial condition

Urologic Diseases

Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.

13,577 public trials 2,146 recruiting studies
Refine in advanced search Browse all conditions

Urologic Diseases trial results

Active, Not Recruiting

Materiovigilance After Urinary Incontinence or Prolapse Surgery

NCT03052985

Conditions
Digestive System Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +18 more
Locations
  • Centre l'Avancée - Clinique Axium Aix-en-Provence, France
  • C.H.U. d'Angers Angers, France
  • CHRU de Besançon Besançon, France
  • Centre Hospitalier de Béthune Béthune, France
View all 31 locations
View Trial Details
Active, Not Recruiting

High Dose IL 2 and Entinostat in RCC

NCT03501381

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Univeristy of Southern California Los Angeles, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Indiana Univeristy Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • Hematology Oncology Clinic, LLC Baton Rouge, Louisiana, United States
View Trial Details
Active, Not Recruiting

Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer

NCT04186013

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Althaia Xarxa Assintencial Manresa, Barcelona, Spain
  • Consorci Corporació Sanitària Parc Taulí Sabadell, Barcelona, Spain
  • Hospital Universitario Sant Joan de Reus Reus, Tarragona, Spain
  • Hospital Clínico Universitario San Cecilio Granada, Spain
View Trial Details
Active, Not Recruiting

Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors

NCT03836352

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +39 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • Cedars Sinai Medical Center: Samuel Oschin Comprehensive Cancer Center Los Angeles, California, United States
  • Boca Raton Regional Hospital, Lynn Cancer Institute Boca Raton, Florida, United States
  • Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer

NCT03308396

Conditions
Adenocarcinoma, Advanced Kidney Cancer, Carcinoma, +16 more
Locations
  • Univerisity of Illinois Cancer Center Chicago, Illinois, United States
  • University of Iowa Hosptials and Clinics Iowa City, Iowa, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
View Trial Details

Related conditions